Women treated for cervical cancer according to the guidelines by tumour stage and time period | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stage IAa (n = 229) | Stage IB-IIAb (n = 398) | Stage IIB-IVAc (n = 406) | Stage IVB (n = 52) | |||||||||||||
1984–1998 | 1999–2008 | 1984–1998 | 1999–2008 | 1984–1998 | 1999–2008 | 1984–1998 | 1999–2008 | |||||||||
Treatment | No./Total | % | No./Total | % | No./Total | % | No./Total | % | No./Total | % | No./Total | % | No./Total | % | No./Total | % |
Surgery alone | 121/152 | 80 | 46/62 | 74 | 95/138 | 69 | 32/36 | 89 | 0/3 | 0 | 0/2 | 0 | 0/0 | - | 0/0 | - |
Surgery + adjuvant radiotherapy | 0/7 | 0 | 0/0 | - | 32/44 | 73 | 8/14 | 57 | 0/2 | 0 | 0/9 | 0 | 0/0 | - | 0/1 | 0 |
Preoperative radiotherapy + surgery | 0/0 | - | 0/0 | - | 5/7 | 71 | 0/2 | 0 | 0/14 | 0 | 0/0 | - | 0/0 | - | 0/0 | - |
Surgery + adjuvant chemotherapy | 0/0 | - | 0/0 | - | 0/2 | 0 | 0/0 | - | 0/0 | - | 0/0 | - | 0/0 | - | 0/1 | 0 |
Radiotherapy alone | 7/7 | 100 | 1/1 | 100 | 99/99 | 100 | 8/9 | 89 | 196/196 | 100 | 0/49 | 0 | 17/17 | 100 | 21/21 | 100 |
Chemo-radiotherapy | 0/0 | - | 0/0 | - | 0/6 | 0 | 22/38 | 58 | 22/22 | 100 | 108/108 | 100 | 0/0 | - | 10/10 | 100 |
Chemotherapy alone | 0/0 | - | 0/0 | - | 0/2 | 0 | 0/1 | 0 | 0/0 | - | 0/1 | 0 | 0/0 | - | 2/2 | 100 |
Total | 128/166 | 77 | 47/63 | 75 | 231/298 | 78 | 70/100 | 70 | 218/237 | 92 | 108/169 | 64 | 17/17 | 100 | 33/35 | 94 |
% (95 % CI) of women treated according to the guidelines | ||||||||||||||||
By tumour stage and time period | 77 % (70–83 %) | 75 % (62–85 %) | 78 % (72–82 %) | 70 % (60–79 %) | 92 % (88–95 %) | 64 % (56–71 %) | 100 % (80–100 %) | 94 % (81–99 %) | ||||||||
By tumour stage in 1984-2008 | 76 % (70–82 %) in 1984–2008 | 76 % (71–80 %) in 1984–2008 | 80 % (76–84 %) in 1984–2008 | 96 % (87–100 %) in 1984–2008 | ||||||||||||
By time period for all tumour stages | 83 % (80–85 %) in 1984–1998, 70 % (65–75 %) in 1999–2008 | |||||||||||||||
Overall | 79 % (76–81 %) in 1984–2008 |